We initiated coverage of Galena Biopharma (NASDAQ:GALE) in mid-November 2011. At that time, the share price of GALE was at about $0.70 per share. As of July 29, 2013, the share price of GALE is $1.77, an appreciation of 153%.
We think the impressive appreciation of share price has been based on many positive developments within the company in the past two years, such as the advancement of the company's clinical programs, expansion of pipeline and boosting of its balance sheet.
After having reaped such an amazing return, the legitimate question investors may ask is: what's next for GALE from here? My answer to this question: there is still enough room for significant price appreciation for GALE in
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|